New Jersey · 2026-2027 Regular Session · Bill
A 5020: Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 5020 is a bill introduced in the New Jersey House on May 7, 2026. According to its official title, it concerns: Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services. Primary sponsor: Peterpaul, Luanne M., Esq.. It lists 1 additional sponsor. Most recent recorded action (May 7, 2026): Introduced, Referred to Assembly Financial Institutions and Insurance Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Peterpaul, Luanne M., Esq. | Primary sponsor | Not applicable (committee) | — | — |
| Kearney, Vincent M. | Co-sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Introduced, Referred to Assembly Financial Institutions and Insurance Committee